We identified that KLF11 functions as a novel transcription factor in vascular endothelial cells (ECs) that potently inhibit pro-inflammatory adhesion molecules, which are crucial for the initiation and maintenance of vascular inflammation, a hallmark in many human diseases including atherosclerosis and diabetes.